Tag Archives: GEVO

Hot High Tech Stocks To Invest In Right Now

Tutor Perini (NYSE:TPC) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “Tutor Perini Corporation provides diversified general contracting, construction management and design-build services to private clients and public agencies worldwide. The company operates in four segments: Civil, Building, Specialty Contractors, and Management Services. The Civil segment engages in public works construction activities and the repair, replacement, and reconstruction of infrastructure. The Building segment offers services in specialized building markets, including hospitality and gaming, transportation, healthcare, municipal offices, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial, and high technology. The Specialty Contractors segment provides plumbing, HVAC, electrical, mechanical, and concrete services for the industrial, commercial, hospitality and gaming, and transportation markets. The Management Services segment offers construction and design-build services to the U.S. military and government agencies, and multi-national corporations. “

Hot High Tech Stocks To Invest In Right Now: Gevo, Inc.(GEVO)

Gevo, Inc. (Gevo), incorporated on June 9, 2005, is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo, Inc. segment also develops, maintains and protects its intellectual property portfolio, develops future markets for its isobutanol and provides corporate oversight services. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.

The Company has developed the Gevo Integrated Fermentation Technology (GIFT), an integrated technology platform for the production and separation of renewable isobutanol in order to produce and sell isobutanol made from renewable sources. GIFT consists of two components: biocatalysts that convert sugars derived from multiple renewable feed stocks into isobutanol through fermentation and a separation unit that is designed to continuously separate isobutanol during the fermentation process. GIFT is designed to permit the retrofit of existing ethanol capacity to produce isobutanol, ethanol or both products simultaneously or the addition of renewable isobutanol or ethanol production capabilities to a facility’s existing ethanol production by adding additional fermentation capacity side-by-side with the facility’s existing ethanol fermentation capacity (collectively refer! red to as Retrofit). Just like ethanol production, after fermentation, a primary product (isobutanol) and a co-product (iDGs) are recovered for sale. The main modifications of the GIFT system are replacing the ethanol producing yeast with Gevo’s isobutanol producing biocatalyst, and adding low temperature distillation equipment for continuous removal and separation of isobutanol. The Company has also developed new technologies using ethanol as a feedstock for the production of hydrocarbons, renewable hydrogen, and other chemical intermediates, which it describes as its ethanol-to-olefins (ETO) technologies. The process produces tailored mixes of isobutylene, propylene, hydrogen and acetone, which are used as standalone molecules, or as feedstocks to produce other chemical products and longer chain alcohols. At this time, this technology has only been operated at a laboratory scale.

The Company competes with Butamax Advanced Biofuels LLC, Cathay Industrial Biotech Ltd., METabolic EXplorer S.A., Eastman Chemicals Company, Green Biologics Ltd., Shell Oil Company, DuPont-Danisco Cellulosic Ethanol LLC, Abengoa Bioenergy, S.A., POET, LLC, ICM, Mascoma Corporation, Inbicon A/S, INEOS New Planet BioEnergy LLC, Coskata, Inc., Archer Daniels Midland Company, BlueFire Ethanol, Inc., IncZeaChem Inc., ZeaChem Inc., Iogen Corporation, Qteros, Inc., Global Bioenergies, S.A., Virent Energy Systems, Inc., Renewable Energy Group, Inc., Amyris Biotechnologies, Inc. and Valero Energy Corporation.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Gevo Inc (NASDAQ:GEVO) traded down 5.9% on Thursday . The company traded as low as $4.12 and last traded at $4.29. 529,018 shares changed hands during mid-day trading, a decline of 36% from the average session volume of 832,918 shares. The stock had previously closed at $4.56.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Gevo (GEVO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot High Tech Stocks To Invest In Right Now: Vascular Biogenics Ltd.(VBLT)

Vascular Biogenics Ltd., incorporated on January 31, 2000, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Company’s program is based on its Vascular Targeting System (VTS) platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. Its lead product candidate, VB-111(ofranergene obadenovec), is a gene-based biologic that it is developing for solid tumor indications, with a program for recurrent glioblastoma (rGBM), a form of brain cancer. It also is engaged in conducting a program focusing anti-inflammatory diseases, based on the use of its Lecinoxoid platform technology. Lecinoxoids are a class of small molecules it developed that are structurally and functionally similar to naturally occurring molecules known to modulate inflammation. The lead product candidate from this program, VB-201, is a Phase II-ready molecule that demonstrated efficacy in reducing vascular inflammation in a Phase II sub-study in psoriatic patients with cardiovascular risk.

VTS Platform

The Company’s VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. VTS is both tissue- and condition-specific, allowing for targeted and limited gene expression in endothelial cells, the thin layer of cells that lines the interior surface of blood vessels undergoing angiogenesis. Its VTS platform technology comprises three components: a viral vector, a promoter and a transgene. The viral vector is a modified virus that is used as a delivery vehicle to distribute the promoter and the transgene throughout the body. The promoter is its genetically modified promoter, PPE-1-3X, which specifically targets the endothelial cells of angiogenic blood vessels. The transgene is a genetic sequence designed to yield a specific biologic effect, the expression of which is directed by PPE-1-3X.

The Company has studied VB-111 in a Phase I all comers trial involving patients with multiple types of metastatic cancer types, including thyroid cancer, neuroendocrine cancer, renal cell carcinoma and lung cancer. In that trial, VB-111 was tolerated and showed a dose- dependent extension in median overall survival across a range of tumor types. Its VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. It has also generated additional product candidates, which utilize the same vector and promoter as in VB-111, and comprise alternative functional transgenes, which include VB-511, an anti-angiogenic candidate; VB-211 and VB-411, which are pro-angiogenic candidates that may be employed for ischemic conditions, such as peripheral vascular disease.

Lecinoxoid Platform

The Company’s Lecinoxoid platform technology comprises a family of orally administered small molecules designed to modulate the body’s inflammatory response. Lecinoxoids are compounds that are structurally and functionally similar to naturally occurring molecules, known as oxidized phospholipids, which possess immune modulating anti-inflammatory properties, modified to manage stability and activity. Its lead Lecinoxoid-based compound, VB-201, is designed as an oral agent for the control of chronic inflammatory disorders. VB-201 inhibits the CD-14/TLR4 and TLR2 pathways, as well as monocyte migration. The Company has also developed second and third generations of Lecinoxoid product candidates.

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading.
    ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday.
    Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
    Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday.
    Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
    Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday.
    Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading.
    Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss.
    Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook.
    ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering

  • [By Lisa Levin] Companies Reporting Before The Bell
    Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion.
    J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion.
    Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion.
    The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million.
    Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million.
    KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million.
    Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share.
    Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million.
    Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

     

Hot High Tech Stocks To Invest In Right Now: PacWest Bancorp(PACW)

PacWest Bancorp, incorporated on March 24, 2008, is a bank holding company for Pacific Western Bank (the Bank). The Company is focused on relationship-based business banking to small, middle-market and venture-backed businesses. The Bank offers a range of loan and deposit products and services through approximately 80 branches located throughout the state of California. The Company provides commercial banking services, and deposit and treasury management services to small and middle-market businesses. It offers products and services under the brand names of Pacific Western, as well as its business groups, CapitalSource Inc. and Square 1 Bank. CapitalSource focuses on providing cash flow, asset-based, equipment and real estate loans and treasury management services to middle market businesses. Square 1 Bank focuses on providing a range of financial products to service entrepreneurial businesses and their venture capital and private equity investors. Square 1 Asset Management, Inc., a subsidiary of the Bank, provides investment advisory and asset management services.

Lending Activities

The Company conducts a range of commercial lending activities that includes real estate mortgage, real estate construction and land loans, and commercial and industrial (C&I) loans and leases. Its commercial real estate loans are secured by a range of property types. Its C&I loan offerings are diverse and include various asset-secured loans, equipment-secured loans and leases, cash flow loans (leveraged loans) to finance business acquisitions and recapitalizations, and venture loans to support the operations of entrepreneurial companies during the various phases of their start-up operations. Its C&I loans include cash flow loans, asset-based loans, equipment-secured loans and leases, and venture capital loans. Its real estate lending activities focuses on loans to professional developers and real estate investors for the acquisition, refinancing and construction of commercial real estate. Its con! sumer loans include personal loans, auto loans, home equity lines of credit, revolving lines of credit, other loans made by banks to individual borrowers, and purchased participation interests in student loans originated and serviced by a third-party lender. The Company’s total loans are approximately $14.48 billion.

Investment Activities

The Company’s investment securities are classified as securities available-for-sale. The Company’s investment portfolio consists of obligations of states and political subdivisions (municipal securities), the United States Government agency obligations, and government-sponsored enterprise (GSE) obligations. The Company owns approximately $3.6 billion of investment securities available-for-sale.

Sources of Funds

The Company’s main source of funds to support its revenue-generating assets and to provide a source of low-cost funds and deposit-related fee income are deposits. The Company offers deposit products to businesses and other customers with a range of rates and terms, including demand, money market and time deposits. It also provides international banking services, multi-state deposit services, asset management services, as well as product offerings through other correspondent banks. The Company’s total deposits consist of approximately $10.6 billion in core deposits, approximately $4.2 billion in time deposits and over $0.9 billion in brokered non-maturity deposits. The Company borrows funds on a long-term, short-term or overnight basis from the Federal Home Loan Banks (FHLB), the Federal Reserve Bank of San Francisco (FRBSF) or other financial institutions.

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine upgraded shares of PacWest Bancorp (NASDAQ:PACW) from a sell rating to a hold rating in a research report report published on Wednesday morning.

  • [By Ethan Ryder]

    PacWest Bancorp (NASDAQ:PACW) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    PagSeguro Digital (NYSE:PAGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Shane Hupp]

    PacWest Bancorp (NASDAQ:PACW) – Stock analysts at Wedbush reduced their Q1 2019 earnings per share estimates for shares of PacWest Bancorp in a research report issued on Wednesday, September 12th. Wedbush analyst D. Chiaverini now forecasts that the financial services provider will earn $0.89 per share for the quarter, down from their prior estimate of $0.90. Wedbush currently has a “Neutral” rating on the stock. Wedbush also issued estimates for PacWest Bancorp’s Q1 2020 earnings at $0.98 EPS and Q2 2020 earnings at $1.02 EPS.

Hot High Tech Stocks To Invest In Right Now: CPS Technologies Corp.(CPSH)

CPS Technologies Corporation produces and sells advanced material solutions to the transportation, automotive, energy, computing/Internet, telecommunication, aerospace, defense, and oil and gas markets. Its products are used in applications that involve energy use or energy generation. The company primarily offers metal matrix composites that are a combination of metal and ceramic, such as baseplates for various applications, including motor controllers used in electric trains, subway cars, wind turbines, and hybrid and electric vehicles; baseplates and housings for use in radar, satellite, and avionics applications, as well as in modules built with wide band gap semiconductors; and lids and heatspreaders used with integrated circuits for use in Internet switches and routers. It also assembles housings and packages for hybrid circuits. CPS Technologies Corporation primarily sells its products to microelectronics systems houses in the United States, Europe, and Asia. The company was formerly known as Ceramics Process Systems Corporation and changed its name to CPS Technologies Corporation in March 2007. CPS Technologies Corporation was incorporated in 1984 and is headquartered in Norton, Massachusetts.

Advisors’ Opinion:

  • [By Max Byerly]

    Media coverage about CPS Technologies (NASDAQ:CPSH) has been trending somewhat negative recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CPS Technologies earned a media sentiment score of -0.04 on Accern’s scale. Accern also gave news headlines about the electronics maker an impact score of 47.6937573591172 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Hot High Tech Stocks To Invest In Right Now: ING Group, N.V.(ISP)

ING Groep N.V. (ING) is a financial institution. The Company offers banking services. The Company’s segments include Retail Netherlands, which offers current and savings accounts, business lending, mortgages and other consumer lending in the Netherlands; Retail Belgium, which offers products are similar to those in the Netherlands; Retail Germany, which offers current and savings accounts, mortgages and other customer lending; Retail Other, which offers products are similar to those in the Netherlands, and Wholesale Banking, which offers wholesale banking activities (a full range of products from cash management to corporate finance), real estate and lease. The Company’s Retail Banking business lines provide products and services to individuals, small and medium-sized enterprises (SMEs) and mid-corporates. ING Bank’s subsidiary in the United States is ING Financial Holdings Corporation. Advisors’ Opinion:

  • [By Logan Wallace]

    Berenberg Bank set a €2.20 ($2.56) price target on Intesa Sanpaolo (BIT:ISP) in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the stock.

  • [By Ethan Ryder]

    Intesa Sanpaolo (BIT:ISP) has been given a €2.15 ($2.50) target price by stock analysts at UBS Group in a research note issued on Tuesday, www.boersen-zeitung.de reports. The firm presently has a “neutral” rating on the stock.

  • [By Stephan Byrd]

    Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.

  • [By Logan Wallace]

    Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.

Hot High Tech Stocks To Invest In Right Now: DraftKings Inc.(DKNG)

DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States. It operates through two segments, Business-to-Consumer and Business-to-Business. The company provides users with daily sports, sports betting, and iGaming opportunities. It is also involved in the design, development, and licensing of sports betting and casino gaming platform software for online and retail sportsbook, and casino gaming products. The company distributes its product offerings through various channels, including traditional websites and direct app downloads, as well as direct-to-consumer digital platforms, such as the Apple App store and the Google Play store. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.

Advisors’ Opinion:

  • [By Thomas Niel]

    Like other “meme stocks,” a lot of the appeal with FUBO stock is its chance of getting short-squeezed. Short interest runs high (currently 17.5% of float), as bears are betting big that the company’s sports streaming/wagering platform will fail to find success due to high competition from big media, as well as from early-movers in the online sportsbook space such as DraftKings (NASDAQ:DKNG).

  • [By Dana Blankenhorn]

    If there’s a stock perfect for the “Bro Investor” who likes risk, action, and (potentially) a big pay-off, it’s DraftKings (NASDAQ:DKNG).

Top Low Price Stocks For 2021

OrganiGram Holdings Inc (CVE:OGI) Director Kenneth Arnold Mitton sold 9,500 shares of the business’s stock in a transaction that occurred on Monday, September 10th. The stock was sold at an average price of C$7.00, for a total value of C$66,500.00.

Kenneth Arnold Mitton also recently made the following trade(s):

Get OrganiGram alerts:

On Friday, September 7th, Kenneth Arnold Mitton sold 11,400 shares of OrganiGram stock. The stock was sold at an average price of C$7.00, for a total value of C$79,800.00.

Shares of OGI traded down C$0.22 during trading hours on Thursday, hitting C$7.56. 1,247,430 shares of the stock were exchanged, compared to its average volume of 1,293,632. OrganiGram Holdings Inc has a 12-month low of C$2.27 and a 12-month high of C$8.07.

Top Low Price Stocks For 2021: Wynn Resorts, Limited(WYNN)

Wynn Resorts, Limited, together with its subsidiaries, develops, owns, and operates destination casino resorts. It operates in two segments, Macau Operations and Las Vegas Operations. The company operates Wynn Macau and Encore at Wynn Macau resort located in the Peoples Republic of China. As of February 13, 2015, its Macau resorts feature had approximately 284,000 square feet of casino space, which offered 24-hour gaming and a range of games with 498 table games and 625 slot machines, private gaming salons, sky casinos, and a poker; 2 luxury hotel towers with a total of 1,008 guest rooms and suites; casual and fine dining in 8 restaurants; approximately 57,000 square feet of retail shopping, including stores and boutiques; approximately 31,000 square feet of space for lounges and meeting facilities; recreation and leisure facilities, including two health clubs, spas, a salon, and a pool; and the Rotunda show. The company also owned and operated Wynn Las Vegas and Encore at Wynn Las Vegas resort with a total of 4,748 hotel rooms, suites, and villas; 232 table games; 1,849 slot machines; a race and sports book and poker room in approximately 186,000 square feet of casino gaming space, including a sky casino and private gaming salons; 34 food and beverage outlets; 2 spas and salons; lounges; and approximately 99,000 square feet of retail shopping space. Its Las Vegas resorts also offer 3 nightclubs and a beach club; a Ferrari and Maserati automobile dealership; wedding chapels; an 18-hole golf course; approximately 290,000 square feet of meeting and convention space; a theater; and two showrooms, as well as a water-based theatrical production and entertainment production. Wynn Resorts, Limited was founded in 2002 and is based in Las Vegas, Nevada.

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Now, here’s a closer look at today’s Money Morning insight, the most important market events, and stocks to watch.

    The Top Stock Market Stories for Tuesday
    Today, investors will keep a close eye on developments out of the White House. The Trump administration has threatened to slap $11 billion in tariffs on the world’s largest economic trade bloc, a move that could heighten trade tensions at a time when the United States is trying to strike a deal with China. The move is reportedly tied to the EU’s ongoing efforts to allegedly offer subsidies to European airline manufacturer Airbus SE (OTCMKTS: EADSF). Products that face tariffs include wine, fish, and cheese. In deal news, Wynn Resorts Ltd. (NASDAQ: WYNN) is picking up its latest acquisition target. CNN reports the firm has offered Crown Resorts a whopping $7.1 billion in a takeover deal. If you’re looking to make big money in the U.S. and international gambling space, be sure to check our best three stocks in the sector, right here. Keep a close eye on Apple Inc. (NASDAQ: AAPL). This morning, the tech giant will look to extend its incredible 10-day winning streak. The stock just received a price target upgrade from Wedbush, from $215 to $225 per share. But if you’ve been following us, you’d know that $225 is our long-term outlook for one of the world’s top companies.
    Stocks to Watch Today: LNN, BAC, BA
    Earnings season kicks into full swing later this week. But investors should keep an eye out for a round of different firms that will be reporting earnings. At the head of the table today is Lindsay Corp.(NYSE: LNN). The firm reported a 21% drop in year-over-year revenue. The firm blamed the decline on divestitures in its irrigation segment.

    Just Revealed: The Secret to Potentially Growing Incredibly Wealthy Buying Straight-Up Stocks

  • [By Garrett Baldwin]

    When the Supreme Court struck down a federal ban on sports gambling, states rushed to legalize the lucrative industry. At the time, most analysts were hawking the big names in the space – the multinational firms like Wynn Resorts Ltd. (NASDAQ: WYNN) and Las Vegas Sands Corp. (NYSE: LVS).

  • [By Rich Duprey]

    Even batteredWynn Resorts (NASDAQ:WYNN), which lost half its value from its high point last year, could see more growth even though it’s gained some 26% this year.

  • [By Money Morning Staff Reports]

    Wynn Resorts Ltd. (NASDAQ: WYNN), the famous Las Vegas casino operation, popped 913% since 2002.

    And the maker of Corona beer and Svedka Vodka, Constellation Brands Inc. (NYSE: STZ), puts the others to shame with an eye-popping 30,638% gain since 1989. That doesn’t even include the dividends you’d have racked up along the way.

Top Low Price Stocks For 2021: U S Concrete, Inc.(USCR)

U.S. Concrete, Inc., through its subsidiaries, produces and sells ready-mixed concrete, aggregates, and concrete-related products and services for the construction industry in the United States. It operates through two segments, Ready-Mixed Concrete and Aggregate Products. The Ready-Mixed Concrete segment is involved in the formulation, preparation, and delivery of ready-mixed concrete to customers job sites; and the provision of various services that include the formulation of mixtures for specific design uses, on-site and lab-based product quality control, and customized delivery programs. The Aggregate Products segment offers crushed stone, sand, and gravel for use in commercial, industrial, and public works projects. The company also engages in the operation of building materials stores; provision of concrete blocks, lime slurry, and Aridus rapid-drying concrete technology; sale of brokered products; hauling and recycled aggregates operation activities; and operation of drum mixer trucks, as well as transfer trucks for transporting cement and aggregates. It primarily serves concrete sub-contractors, general contractors, governmental agencies, property owners and developers, architects, engineers, and home builders in north and west Texas, California, New Jersey, New York, Washington, D.C., and Oklahoma. U.S. Concrete, Inc. was founded in 1948 and is headquartered in Euless, Texas.

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Shares of U.S. Concrete(NASDAQ:USCR) gained 12.5% in February, according to data provided by S&P Global Market Intelligence. That advance, however, came in the wake of horrid performance in 2018: Through February, the stock had lost roughly half its value since the start of last year. But the news here isn’t all bad.

  • [By Motley Fool Transcribing]

    US Concrete (NASDAQ:USCR) Q4 2018 Earnings Conference CallFeb. 26, 2019 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on US Concrete (USCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Three growth stocks I’d buy right now are animal health leader Zoetis (NYSE:ZTS), ready-mix concrete specialistU.S. Concrete (NASDAQ:USCR), and leading biodiesel producerRenewable Energy Group (NASDAQ:REGI). Here’s why.

Top Low Price Stocks For 2021: Potash Corporation of Saskatchewan Inc.(POT)

Potash Corporation of Saskatchewan Inc. (PCS), incorporated on May 15, 2002, is a fertilizer producer producing various primary crop nutrients, such as potash, nitrogen and phosphate. The Company operates through three segments: potash, nitrogen and phosphate. The Company owns and operates approximately five potash operations in Saskatchewan and one in New Brunswick. Its nitrogen operations involve the production of nitrogen fertilizers and nitrogen feed and industrial products, including ammonia, urea, nitrogen solutions, ammonium nitrate and nitric acid. It has nitrogen facilities in Georgia, Louisiana, Ohio and Trinidad. The Company’s phosphate operations include the manufacture and sale of solid and liquid phosphate fertilizers, phosphate feed and industrial acid, which is used in food products and industrial processes. It has phosphate mines and mineral processing plant complexes in Florida and North Carolina. The Company has approximately four phosphate feed plants in the United States and produce phosphoric acid at its Geismar, Louisiana facility.

Potash

The Company’s potash operations include the mining and processing of potash, which is used as fertilizer. The potash ore is contained in a rock salt formation known as the Prairie Evaporite, which lies approximately 1,000 meters below the surface. The evaporite deposits, which are bounded by limestone formations, contain potash beds of 2.4 to 5.1 meters of thickness. The potash deposits that occur in the Province are the Esterhazy, Belle Plaine and Patience Lake Members. The Patience Lake Member is mined at the Lanigan, Allan, Patience Lake and Cory mines, and the Esterhazy Member is mined at the Rocanville mine. The Company produces potash using both conventional and solution mining methods. The Company’s conventional potash operations mine approximately 28.2 million tons of ore at an average mineral grade of over 23.7% potassium oxide (K2O). Its potash production from its operations consists of over 9.1 million tons ! of potash (KCl or finished product) with an average grade of 61.0% K2O. In addition to potash production, its New Brunswick operations also produces over 0.9 million tons of sodium chloride (salt).

Nitrogen

The Company’s nitrogen operations include the production of nitrogen fertilizers and nitrogen chemicals. Its products are used for agricultural, industrial and animal nutrition purposes. The Company has over four nitrogen production facilities, of which over three are located in the United States and one is located in Trinidad. The Company’s plant locations are Augusta, GA, which produces ammonia, urea, nitric acid, ammonium nitrate and nitrogen solutions; Geismar, LA, which produces ammonia, nitric acid and nitrogen solutions; Lima, OH, which produces ammonia, urea, nitric acid and nitrogen solutions, and Point Lisas, Trinidad, which produces Ammonia and urea. The ammonia is used to produce a line of upgraded nitrogen products, including urea, nitrogen solutions, ammonium nitrate and nitric acid. Ammonia, urea and nitrogen solutions are sold as fertilizers to agricultural customers and to industrial customers for various applications. Nitric acid and ammonium nitrate are sold to industrial customers for various applications. Urea is also sold for feed applications.

Phosphate

The Company mines phosphate ore and manufactures phosphoric acid, solid and liquid fertilizers, animal feed supplements, purified phosphoric acid, which is used in food products and industrial processes, hydrofluosilicic acid (HFSA) and silicon tetrafluoride (STF). The Company conducts its phosphate operations primarily at over two facilities, including a 75,212-acre facility near Aurora, North Carolina and a 99,588-acre facility near White Springs in northern Florida. The Aurora facility includes approximately six million ton per-year mining operation, over three sulfuric acid plants, approximately four phosphoric acid plants, over four purified acid plants, a liquid fertilize! r plant, ! approximately four superphosphoric acid (SPA) plants, a deflourinated merchange grade acid plant (DFMGA), a low magnesium SPA plant (LOMAG), a defluorinated phosphate (DFP) or animal feed plant, approximately two granulation plants capable of producing diammonium phosphate (DAP) or monoammonium phosphate (MAP), and over four STF plants.

The White Springs facility includes a mine and the Swift Creek chemical complex. The remaining Swift Creek chemical complex consists of over two sulfuric acid plants, one phosphoric acid plant, and one SPA plant. At its Geismar, Louisiana facility, the Company manufactures phosphoric acid. The Geismar facility has a phosphoric acid plant and a liquid fertilizer plant. The Company extracts phosphate ore using surface mining techniques. Its other phosphate properties include animal feed plants in Marseilles, Illinois; Joplin, Missouri; Weeping Water, Nebraska; a technical and food grade phosphate plant in Cincinnati, Ohio, and a terminal facility at Morehead City, North Carolina. It produces MGA at Aurora, White Springs and Geismar facilities.

The Company competes with The Mosaic Company, Agrium Inc., Intrepid Potash Inc., ICL, SQM, Belaruskali, Uralkali, K+S Group, Agrium Inc., CF Industries Holdings, Inc., Koch Industries, Inc., J.R. Simplot Company, OCP S.A. and Innophos Holdings, Inc.

Advisors’ Opinion:

  • [By Shane Hupp]

    Media stories about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended somewhat positive recently, Accern reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Potash Co. of Saskatchewan earned a daily sentiment score of 0.23 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.852138495875 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Ethan Ryder]

    Headlines about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Potash Co. of Saskatchewan earned a news impact score of 0.43 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.4285202328488 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    PotCoin (CURRENCY:POT) traded 0.6% higher against the US dollar during the 24 hour period ending at 23:00 PM E.T. on May 12th. PotCoin has a total market capitalization of $23.95 million and approximately $62,522.00 worth of PotCoin was traded on exchanges in the last 24 hours. During the last seven days, PotCoin has traded 17.8% lower against the US dollar. One PotCoin coin can now be purchased for approximately $0.11 or 0.00001293 BTC on popular cryptocurrency exchanges including Cryptopia, CoinExchange, Trade By Trade and Tux Exchange.

Top Low Price Stocks For 2021: AmerisourceBergen Corporation (Holding Co)(ABC)

AmerisourceBergen Corporation, incorporated on March 16, 2001, is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Company also provides data and other services to its manufacturing customers. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States. Its services for manufacturers include assistance with product launches, promotional and marketing services to accelerate product sales, product data reporting and logistical support. The Company is a provider of solutions, including the Good Neighbor Pharmacy program, which enables independent community pharmacies; Elevate Provider Network, a managed care network, which connects the retail pharmacy customers to payor plans throughout the country; generic product purchasing and private label services; hospital pharmacy consulting, and packaging solutions for institutional and retail healthcare providers.

Pharmaceutical Distribution Segment

The Pharmaceutical Distribution segment consists of the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG). Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment’s operations provide drug distribution and related services. ABDC distributes an offering of brand-name and generic pharmaceuticals (including specialty pharmaceutical products), over-the-counter healthcare products, home healthcare supplies and equipment! , and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. ABDC also provides pharmacy management, staffing and other consulting services, and supply management software to various retail and institutional healthcare providers. Additionally, ABDC delivers packaging solutions to institutional and retail healthcare providers.

ABSG, through a range of operating businesses, provides pharmaceutical distribution and other services to physicians who specialize in various disease states, especially oncology, and to other healthcare providers, including hospitals and dialysis clinics. ABSG also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products. Additionally, ABSG provides third-party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers.

Other

The Other segment consists of the operations of AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. (World Courier) and the MWI Veterinary Supply, Inc. (MWI). ABCS, through a range of operating businesses, provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers. World Courier, which operates in over 50 countries, is a global specialty transportation and logistics provider for the biopharmaceutical industry. MWI is an animal health distribution company in the United States and in the United Kingdom. MWI sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients and various other products to customers in both the companion an! imal and ! production animal markets.

The Company competes with McKesson Corporation, Cardinal Health, Inc., FFF Enterprises, Henry Schein, Inc. and UPS Logistics.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Peel Hunt restated their buy rating on shares of Abcam (LON:ABC) in a report issued on Monday morning.

    A number of other equities research analysts have also commented on ABC. Numis Securities upgraded Abcam to an add rating and set a GBX 1,340 ($17.51) target price on the stock in a research report on Tuesday, January 8th. JPMorgan Chase & Co. reiterated a neutral rating on shares of Abcam in a research report on Thursday, January 10th. Finally, Berenberg Bank reiterated a buy rating and issued a GBX 1,640 ($21.43) target price on shares of Abcam in a research report on Tuesday, January 8th.

  • [By Ethan Ryder]

    COPYRIGHT VIOLATION NOTICE: “Sivik Global Healthcare LLC Has $744,000 Holdings in AmerisourceBergen Corp. (ABC)” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4194514/sivik-global-healthcare-llc-has-744000-holdings-in-amerisourcebergen-corp-abc.html.

  • [By Stephan Byrd]

    Golub Group LLC increased its holdings in shares of AmerisourceBergen Corp. (NYSE:ABC) by 11.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,519 shares of the company’s stock after purchasing an additional 1,691 shares during the quarter. Golub Group LLC’s holdings in AmerisourceBergen were worth $1,229,000 at the end of the most recent reporting period.

Top Low Price Stocks For 2021: Gevo, Inc.(GEVO)

Gevo, Inc. (Gevo), incorporated on June 9, 2005, is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo, Inc. segment also develops, maintains and protects its intellectual property portfolio, develops future markets for its isobutanol and provides corporate oversight services. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.

The Company has developed the Gevo Integrated Fermentation Technology (GIFT), an integrated technology platform for the production and separation of renewable isobutanol in order to produce and sell isobutanol made from renewable sources. GIFT consists of two components: biocatalysts that convert sugars derived from multiple renewable feed stocks into isobutanol through fermentation and a separation unit that is designed to continuously separate isobutanol during the fermentation process. GIFT is designed to permit the retrofit of existing ethanol capacity to produce isobutanol, ethanol or both products simultaneously or the addition of renewable isobutanol or ethanol production capabilities to a facility’s existing ethanol production by adding additional fermentation capacity side-by-side with the facility’s existing ethanol fermentation capacity (collectively refer! red to as Retrofit). Just like ethanol production, after fermentation, a primary product (isobutanol) and a co-product (iDGs) are recovered for sale. The main modifications of the GIFT system are replacing the ethanol producing yeast with Gevo’s isobutanol producing biocatalyst, and adding low temperature distillation equipment for continuous removal and separation of isobutanol. The Company has also developed new technologies using ethanol as a feedstock for the production of hydrocarbons, renewable hydrogen, and other chemical intermediates, which it describes as its ethanol-to-olefins (ETO) technologies. The process produces tailored mixes of isobutylene, propylene, hydrogen and acetone, which are used as standalone molecules, or as feedstocks to produce other chemical products and longer chain alcohols. At this time, this technology has only been operated at a laboratory scale.

The Company competes with Butamax Advanced Biofuels LLC, Cathay Industrial Biotech Ltd., METabolic EXplorer S.A., Eastman Chemicals Company, Green Biologics Ltd., Shell Oil Company, DuPont-Danisco Cellulosic Ethanol LLC, Abengoa Bioenergy, S.A., POET, LLC, ICM, Mascoma Corporation, Inbicon A/S, INEOS New Planet BioEnergy LLC, Coskata, Inc., Archer Daniels Midland Company, BlueFire Ethanol, Inc., IncZeaChem Inc., ZeaChem Inc., Iogen Corporation, Qteros, Inc., Global Bioenergies, S.A., Virent Energy Systems, Inc., Renewable Energy Group, Inc., Amyris Biotechnologies, Inc. and Valero Energy Corporation.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Gevo Inc (NASDAQ:GEVO) traded down 5.9% on Thursday . The company traded as low as $4.12 and last traded at $4.29. 529,018 shares changed hands during mid-day trading, a decline of 36% from the average session volume of 832,918 shares. The stock had previously closed at $4.56.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Gevo (GEVO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of Gevo, Inc. (NASDAQ:GEVO) saw strong trading volume on Monday . 4,144,466 shares changed hands during trading, an increase of 374% from the previous session’s volume of 873,478 shares.The stock last traded at $4.72 and had previously closed at $3.98.

Top Heal Care Stocks To Watch For 2019

Media stories about Argan (NYSE:AGX) have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Argan earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned news stories about the construction company an impact score of 45.7492523122329 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Shares of AGX traded down $0.15 during mid-day trading on Thursday, hitting $40.20. 3,174 shares of the company’s stock were exchanged, compared to its average volume of 105,491. Argan has a 52 week low of $34.90 and a 52 week high of $69.95. The stock has a market capitalization of $626.64 million, a PE ratio of 11.15 and a beta of 0.85.

Top Heal Care Stocks To Watch For 2019: ANI Pharmaceuticals, Inc.(ANIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Max Byerly]

    Mallinckrodt (NYSE: MNK) and ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

  • [By Joseph Griffin]

    Headlines about ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) have been trending somewhat negative recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. ANI Pharmaceuticals Inc Common Stock earned a media sentiment score of -0.08 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 48.3270217581665 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top Heal Care Stocks To Watch For 2019: Gevo, Inc.(GEVO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Gevo, Inc. (NASDAQ:GEVO) reached a new 52-week high and low on Friday . The company traded as low as $0.22 and last traded at $0.23, with a volume of 20863 shares changing hands. The stock had previously closed at $0.27.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Gevo (GEVO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Gevo (NASDAQ:GEVO) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

  • [By Logan Wallace]

    Shares of Gevo, Inc. (NASDAQ:GEVO) saw strong trading volume on Monday . 4,144,466 shares changed hands during trading, an increase of 374% from the previous session’s volume of 873,478 shares.The stock last traded at $4.72 and had previously closed at $3.98.

Top Heal Care Stocks To Watch For 2019: iShares iBoxx $ High Yield Corporate Bd (HYG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Traders purchased shares of iShares iBoxx $ High Yield Corporate Bond ETF (NYSEARCA:HYG) on weakness during trading hours on Monday. $192.39 million flowed into the stock on the tick-up and $84.01 million flowed out of the stock on the tick-down, for a money net flow of $108.38 million into the stock. Of all equities tracked, iShares iBoxx $ High Yield Corporate Bond ETF had the 8th highest net in-flow for the day. iShares iBoxx $ High Yield Corporate Bond ETF traded down ($0.06) for the day and closed at $85.83

  • [By Shane Hupp]

    Analysts expect that Hydrogenics Co. (NASDAQ:HYGS) (TSE:HYG) will announce sales of $10.65 million for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Hydrogenics’ earnings, with estimates ranging from $10.30 million to $11.00 million. Hydrogenics posted sales of $7.49 million in the same quarter last year, which suggests a positive year-over-year growth rate of 42.2%. The company is scheduled to issue its next earnings results on Wednesday, August 1st.

  • [By WWW.GURUFOCUS.COM]

    For the details of Summit Rock Advisors, LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Summit+Rock+Advisors%2C+LLC

    These are the top 5 holdings of Summit Rock Advisors, LLCiShares Core MSCI Emerging Markets (IEMG) – 754,105 shares, 52.51% of the total portfolio. Shares added by 8.46%iShares MSCI ACWI Index Fund (ACWI) – 516,128 shares, 45.53% of the total portfolio. Shares added by 194.10%iShares iBoxx $ High Yield Corporate Bond (HYG) – 18,330 shares, 1.96% of the total portfolio. Shares reduced by

Top Heal Care Stocks To Watch For 2019: Orion Marine Group Inc(ORN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the media headlines that may have impacted Accern Sentiment’s rankings:

    Get Orion Group alerts:

    Analysts Anticipate Orion Group Holdings Inc (ORN) Will Announce Quarterly Sales of $165.45 Million (americanbankingnews.com) Factors Setting the Tone for Dycom (DY) in Q2 Earnings (finance.yahoo.com) Analysts Expect Orion Group Holdings Inc (ORN) Will Announce Earnings of $0.02 Per Share (americanbankingnews.com) Who Are The Major Shareholders Of Orion Investment SA (WSE:ORN)? (finance.yahoo.com) Arnold Van Den Berg Trims Enstar Group, Exits Orion Group (finance.yahoo.com)

    ORN has been the topic of a number of research analyst reports. Zacks Investment Research lowered Orion Group from a “buy” rating to a “hold” rating in a research report on Tuesday, August 7th. ValuEngine upgraded Orion Group from a “sell” rating to a “hold” rating in a report on Saturday, May 26th. Canaccord Genuity restated a “buy” rating and issued a $10.00 price objective on shares of Orion Group in a report on Thursday, August 2nd. Noble Financial set a $10.00 price objective on Orion Group and gave the company a “buy” rating in a report on Friday, August 3rd. Finally, B. Riley raised their price objective on Orion Group from $10.00 to $11.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $10.13.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Orion Group (ORN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Orion Group (ORN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Orion Group (ORN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Watch For 2019: Sony Corp Ord(SNE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Sony (NYSE: SNE) and Knowles (NYSE:KN) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

  • [By Max Byerly]

    Summit Trail Advisors LLC boosted its holdings in shares of Sony Corp (NYSE:SNE) by 1,217.3% in the 1st quarter, Holdings Channel reports. The firm owned 30,944 shares of the company’s stock after buying an additional 28,595 shares during the period. Summit Trail Advisors LLC’s holdings in Sony were worth $1,450,000 at the end of the most recent reporting period.

  • [By Leo Sun]

    Sony’s (NYSE:SNE) PlayStation Now, which streams more than 650 PS4, PS3, and PS2 games to PS4 consoles and PCs, is the most developed cloud gaming platform in the world. However, Nintendo (NASDAQOTH:NTDOY) has taken several steps into cloud gaming that raise interesting questions about the fledgling market’s future.

  • [By Wayne Duggan]

    In 2000, Sony Corp (ADR) (NYSE: SNE) released the Playstation 2 gaming system in Japan. In Bush vs. Gore, the Supreme Court ruled to end the presidential vote recount in Florida following the 2000 election, making George W. Bush president. Average annual U.S. income was $40,343.

  • [By Anders Bylund]

    Let’s start with Miller’s short-and-sweet analysis. It’s certainly true that Lions Gate is a simpler story than many of its sector peers. Disney (NYSE:DIS) is embroiled in a massive attempt to buy out 21st Century Fox, making both of those stocks harder to evaluate. Sony (NYSE:SNE) is only partly a media company, more deeply invested into consumer electronics.

  • [By Timothy Green]

    I won’t sugarcoat it: Microsoft’s (NASDAQ:MSFT) Xbox One game console has been a disappointment. The software giant has sold 37.5 million Xbox One consoles globally since launch, according to VGChartz. That pales in comparison to the 79.5 million PlayStation 4 consoles Sony (NYSE:SNE) has put into gamers’ living rooms. And Nintendo’s Switch console, launched in 2017, is quickly catching up.

Top 10 Heal Care Stocks To Buy Right Now

What happened

SMART Global Holdings(NASDAQ:SGH)stock rose 43.5% in March, according to data provided byS&P Global Market Intelligence.

The stock gains correlated with SMART’s announcement that its executive chairman, Ajay Shah, would become the company’s new CEO, replacing Iain MacKenzie after a transitional period. This was followed by a strong second-quarter earnings release and a fresh round of favorable ratings coverage.

SGH data by YCharts

So what

On the heels of announcing Shah as the company’s new chief executive, the stock received a round of positive coverage from ratings firms. The company reported second-quarter earnings on March 22, delivering an 83% year-over-year revenue increase to reach $314 million in sales for the period and gross profit climbed 96% to hit $73 million. These top and bottom-line results both came in well above the average analyst estimates.

Top 10 Heal Care Stocks To Buy Right Now: Cliffs Natural Resources Inc.(CLF)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By WWW.GURUFOCUS.COM]

    For the details of Gallagher Fiduciary Advisors, LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Gallagher+Fiduciary+Advisors%2C+LLC

    These are the top 5 holdings of Gallagher Fiduciary Advisors, LLCFifth Third Bancorp (FITB) – 7,424,558 shares, 43.91% of the total portfolio. New PositionUnited States Steel Corp (X) – 3,763,643 shares, 25.82% of the total portfolio. Franklin Resources Inc (BEN) – 1,825,092 shares, 15.42% of the total portfolio. Shares reduced by 2.44%Cleveland-Cliffs Inc (CLF) – 1,780,977 shares, 2.5% of the total portfolio. Shares reduced by 1.33%Finisar Corp (FNSR) – 349,639 shares, 1.39% of t

  • [By Garrett Baldwin]

    Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems.
    Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices “artificially high” despite “record amounts of oil all over the place.” Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel.
    Three Stocks to Watch Today: PM, MO, WFC
    Shares of Philip Morris International Inc.(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day.
    Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of “alleged” misdeeds that include the firm’s push on customers to purchase auto insurance they didn’t need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money MorningCapital Wave StrategistShah Gilani weighed in on the topic this week, and he offers a scorching indictment.
    Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi

  • [By Tyler Crowe]

    At first glance, Cleveland-Cliffs’ (NYSE:CLF) most recent earnings report might make shareholders want to push the sell button as fast as they can open their brokerage accounts. But before you precipitously sour on this iron miner, take a deeper look at its results. Even though its revenue and earnings were down drastically, those declines were largely a product of its moves to shut down unprofitable assets.

Top 10 Heal Care Stocks To Buy Right Now: Quidel Corporation(QDEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Quidel (NASDAQ:QDEL)‘s stock had its “buy” rating reiterated by Barclays in a research note issued on Thursday. They currently have a $65.00 price objective on the stock. Barclays’ price target suggests a potential upside of 8.06% from the company’s previous close.

  • [By Stephan Byrd]

    Birchview Capital LP decreased its stake in Quidel Co. (NASDAQ:QDEL) by 12.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,975 shares of the company’s stock after selling 5,000 shares during the period. Quidel makes up 1.2% of Birchview Capital LP’s portfolio, making the stock its 9th largest holding. Birchview Capital LP’s holdings in Quidel were worth $1,760,000 as of its most recent SEC filing.

Top 10 Heal Care Stocks To Buy Right Now: National Health Investors, Inc.(NHI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Virginia Retirement Systems ET AL lifted its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,300 shares of the real estate investment trust’s stock after acquiring an additional 10,700 shares during the period. Virginia Retirement Systems ET AL owned approximately 0.28% of National Health Investors worth $7,826,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 Heal Care Stocks To Buy Right Now: Gevo, Inc.(GEVO)

Advisors’ Opinion:

  • [By Max Byerly]

    Amyris Biotechnologies (NASDAQ: AMRS) and Gevo (NASDAQ:GEVO) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

Top 10 Heal Care Stocks To Buy Right Now: Pebblebrook Hotel Trust(PEB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Pebblebrook Hotel (PEB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the news stories that may have effected Accern’s analysis:

    Get Pebblebrook Hotel alerts:

    Pebblebrook Hotel (PEB) Expected to Post Quarterly Sales of $206.07 Million (americanbankingnews.com) Keep Company Secrets Safe With a Strong Publishing Process (cmswire.com) Analysts Anticipate Pebblebrook Hotel (PEB) to Post $0.73 Earnings Per Share (americanbankingnews.com) Pebblebrook Hotel Forecasted to Earn Q2 2018 Earnings of $0.72 Per Share (PEB) (americanbankingnews.com)

    A number of brokerages recently issued reports on PEB. Boenning Scattergood restated a “hold” rating on shares of Pebblebrook Hotel in a report on Monday, April 30th. Zacks Investment Research upgraded Pebblebrook Hotel from a “hold” rating to a “strong-buy” rating and set a $40.00 target price on the stock in a report on Wednesday, May 2nd. Robert W. Baird lifted their target price on Pebblebrook Hotel from $37.00 to $38.00 and gave the stock a “hold” rating in a report on Tuesday, May 1st. Finally, ValuEngine cut Pebblebrook Hotel from a “strong-buy” rating to a “buy” rating in a report on Monday, April 2nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Pebblebrook Hotel presently has an average rating of “Buy” and a consensus price target of $36.61.

  • [By Matthew DiLallo]

    Improving business travel demand during the first quarter drove Pebblebrook Hotel Trust (NYSE:PEB) to update its outlook earlier this month. Those travel trends turned out to be stronger than even its more optimistic expectations, helping the company to deliver results that were above the updated forecast. Because of that, the company is even more encouraged about what lies ahead in 2018.

Top 10 Heal Care Stocks To Buy Right Now: Euro Tech Holdings Company Limited(CLWT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Lisa Levin]

    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares shot up 49 percent to $4.775 after reporting 2017 year-end results.

    Shares of Medigus Ltd. (NASDAQ: MDGS) got a boost, shooting up 34 percent to $1.5092 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.

Top 10 Heal Care Stocks To Buy Right Now: Inovio Pharmaceuticals, Inc.(INO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Inovio Pharmaceuticals (NASDAQ:INO) last posted its earnings results on Wednesday, May 9th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.22). Inovio Pharmaceuticals had a negative net margin of 292.06% and a negative return on equity of 72.04%. The company had revenue of $1.53 million during the quarter, compared to analyst estimates of $7.50 million. During the same quarter last year, the business posted ($0.31) EPS. research analysts expect that Inovio Pharmaceuticals Inc will post -1.2 EPS for the current fiscal year.

  • [By Jim Robertson]

    On Tuesday, small capInovio Pharmaceuticals (NASDAQ: INO) surged 22.63% after announcingthat its synthetic vaccine approach using a collection of synthetic DNA antigens generated broad protective antibody responses against all major deadly strains of H1 influenza viruses from the last 100 years. This includesthe virus that caused Spanish Flu in 1918. The study involvedmultiple animal models, including mice, guinea pigs and non-human primates. Given how bad flu season is this year, the announcement got plenty of attention asthe following technical chart shows:

Top 10 Heal Care Stocks To Buy Right Now: United States Cellular Corporation(USM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    U.S. Cellular (NYSE: USM) and Hutchison Telecommunications Hong Kong (OTCMKTS:HTHKY) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

  • [By Ethan Ryder]

    NII (NASDAQ: NIHD) and U.S. Cellular (NYSE:USM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.

Top 10 Heal Care Stocks To Buy Right Now: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

Top 10 Heal Care Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Brian Orelli]

    The delay in an FDA decision for Tegsedi puts it behind competitor Alnylam Pharmaceuticals (NASDAQ:ALNY), which expects to hear from the FDA by Aug. 11 for its hATTR drug patisiran. But Sarah Boyce, the president at Akcea Therapeutics, doesn’t think a few months will really matter: “We don’t really feel that’s going to have any impact and the drugs will be close enough together from a launch perspective. So not really [going] to make any adjustments, and we’re very well prepared to be ready to launch following approval.”

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) released first-quarter results last week, but all eyes were looking forward as the company waits for a potential approval of its hereditary TTR amyloidosis (ATTR) drug, patisiran.

  • [By Max Byerly]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.